Cyltezo
adalimumab-adbm · KIT · Boehringer Ingelheim Pharmaceuticals, Inc.
Cyltezo is a prescription injectable medication containing adalimumab-adbm, a biologic drug used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It works by suppressing the immune system to reduce inflammation and symptoms in these chronic conditions.
Key Facts
- Brand Name
- Cyltezo
- Generic Name
- adalimumab-adbm
- NDC Code (Product)
0597-0370- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761058
- Marketing Start
- 07/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Cyltezo used for?
Cyltezo is a prescription injectable medication containing adalimumab-adbm, a biologic drug used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It works by suppressing the immune system to reduce inflammation and symptoms in these chronic conditions.
Is Cyltezo a controlled substance?
Cyltezo is not classified as a controlled substance by the DEA.
What is the generic name for Cyltezo?
The generic name for Cyltezo is adalimumab-adbm. There are 9 other brand versions of adalimumab-adbm.
What is the NDC code for Cyltezo ?
The NDC (National Drug Code) for Cyltezo is 0597-0370, listed by Boehringer Ingelheim Pharmaceuticals, Inc..